Allergan pays $750m to resolve antitrust litigation

Allergan has reached a $750 million deal to resolve antitrust litigation brought against its subsidiary Forest Laboratories over Alzheimer’s drug Namenda (memantine hydrochloride).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Allergan agrees to pay $300m to end birth control litigation

8 January 2020 Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.

Americas

Generic drugmaker to pay $3m antitrust fine

5 December 2019 New Jersey-based generic drugmaker Rising Pharmaceuticals has admitted to conspiring to fix prices and allocate customers for a generic hypertension drug.

Americas

Amneal and others pay $1.5m to settle antitrust suit over Alzheimer’s drug

20 August 2019 Amneal and three other generic makers have agreed to pay $1.54 million to settle a class-action lawsuit, which alleged the companies engaged in an unlawful scheme to maintain their monopoly over an Alzheimer’s drug.

More on this story

Americas

Allergan agrees to pay $300m to end birth control litigation

8 January 2020 Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.

Americas

Generic drugmaker to pay $3m antitrust fine

5 December 2019 New Jersey-based generic drugmaker Rising Pharmaceuticals has admitted to conspiring to fix prices and allocate customers for a generic hypertension drug.

Americas

Amneal and others pay $1.5m to settle antitrust suit over Alzheimer’s drug

More on this story

Americas

Allergan agrees to pay $300m to end birth control litigation

8 January 2020 Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.

Americas

Generic drugmaker to pay $3m antitrust fine

5 December 2019 New Jersey-based generic drugmaker Rising Pharmaceuticals has admitted to conspiring to fix prices and allocate customers for a generic hypertension drug.

Americas

Amneal and others pay $1.5m to settle antitrust suit over Alzheimer’s drug